Biggest changeThe CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below. 31 Table of Contents The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands ): Year Ended December 31, 2022 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 900,231 $ 128,854 $ – $ 1,029,085 Other revenues 136 – 45,060 45,196 Government stimulus income 11,457 – – 11,457 Net operating revenues and grant income 911,824 128,854 45,060 1,085,738 Costs and Expenses: Salaries, wages and benefits 580,707 77,688 27,774 686,169 Other operating 251,355 26,319 11,698 289,372 Facility rent 32,956 2,327 5,694 40,977 Depreciation and amortization 36,522 691 3,276 40,489 Interest 563 – – 563 Recovery of assets – – (3,728 ) (3,728 ) Total costs and expenses 902,103 107,025 44,714 1,053,842 Income before non-operating income 9,721 21,829 346 31,896 Non-operating income – – 11,141 11,141 Unrealized losses on marketable equity securities – – (15,806 ) (15,806 ) Income (loss) before income taxes $ 9,721 $ 21,829 $ (4,319 ) $ 27,231 Year Ended December 31, 2021 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 868,687 $ 96,855 $ – $ 965,542 Other revenues 386 – 45,014 45,400 Government stimulus income 63,360 – – 63,360 Net operating revenues and grant income 932,433 96,855 45,014 1,074,302 Costs and Expenses: Salaries, wages and benefits 557,604 59,226 49,233 666,063 Other operating 238,354 16,053 12,347 266,754 Facility rent 32,819 2,064 5,935 40,818 Depreciation and amortization 36,890 443 3,339 40,672 Interest 845 – – 845 Impairment of assets 4,497 – 3,728 8,225 Total costs and expenses 871,009 77,786 74,582 1,023,377 Income (loss) before non-operating income 61,424 19,069 (29,568 ) 50,925 Non-operating income – – 17,774 17,774 Gain on acquisition of equity method investment – – 95,202 95,202 Unrealized losses on marketable equity securities – – (13,863 ) (13,863 ) Income before income taxes $ 61,424 $ 19,069 $ 69,545 $ 150,038 32 Table of Contents Year Ended December 31, 2020 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 879,693 $ 52,102 $ – $ 931,795 Other revenues 3,403 – 45,514 48,917 Government stimulus income 47,505 – – 47,505 Net operating revenues and grant income 930,601 52,102 45,514 1,028,217 Costs and Expenses: Salaries, wages and benefits 546,188 37,377 37,427 620,992 Other operating 254,230 10,416 10,513 275,159 Facility rent 33,090 1,802 5,602 40,494 Depreciation and amortization 38,217 377 3,424 42,018 Interest 1,374 – 25 1,399 Total costs and expenses 873,099 49,972 56,991 980,062 Income (loss) before non-operating income 57,502 2,130 (11,477 ) 48,155 Non-operating income – – 26,527 26,527 Gain on acquisition of equity method investment – – 1,707 1,707 Unrealized losses on marketable equity securities – – (23,966 ) (23,966 ) Income (loss) before income taxes $ 57,502 $ 2,130 $ (7,209 ) $ 52,423 Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods.
Biggest changeThe CODM does not review assets by segment in his resource allocation and therefore, assets by segment are not disclosed below. 30 Table of Contents The following tables set forth the Company’s consolidated statements of operations by business segment (in thousands ): Year Ended December 31, 2023 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 956,077 $ 131,537 $ – $ 1,087,614 Other revenues 1,141 – 52,789 53,930 Net operating revenues 957,218 131,537 52,789 1,141,544 Costs and Expenses: Salaries, wages and benefits 589,279 80,610 42,455 712,344 Other operating 254,559 23,529 10,095 288,183 Facility rent 33,787 2,172 5,566 41,525 Depreciation and amortization 38,172 786 3,076 42,034 Interest 324 – – 324 Total costs and expenses 916,121 107,097 61,192 1,084,410 Income (loss) before non-operating income 41,097 24,440 (8,043 ) 57,134 Non-operating income – – 16,660 16,660 Unrealized gains on marketable equity securities – – 14,944 14,944 Income before income taxes $ 41,097 $ 24,440 $ 23,201 $ 88,738 Year Ended December 31, 2022 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 900,231 $ 128,854 $ – $ 1,029,085 Other revenues 136 – 45,060 45,196 Government stimulus income 11,457 – – 11,457 Net operating revenues and grant income 911,824 128,854 45,060 1,085,738 Costs and Expenses: Salaries, wages and benefits 580,707 77,688 27,774 686,169 Other operating 251,355 26,319 11,698 289,372 Facility rent 32,956 2,327 5,694 40,977 Depreciation and amortization 36,522 691 3,276 40,489 Interest 563 – – 563 Recovery of assets – – (3,728 ) (3,728 ) Total costs and expenses 902,103 107,025 44,714 1,053,842 Income before non-operating income 9,721 21,829 346 31,896 Non-operating income – – 11,141 11,141 Unrealized losses on marketable equity securities – – (15,806 ) (15,806 ) Income (loss) before income taxes $ 9,721 $ 21,829 $ (4,319 ) $ 27,231 31 Table of Contents Year Ended December 31, 2021 Inpatient Services Homecare and Hospice All Other Total Revenues: Net patient revenues $ 868,687 $ 96,855 $ – $ 965,542 Other revenues 386 – 45,014 45,400 Government stimulus income 63,360 – – 63,360 Net operating revenues and grant income 932,433 96,855 45,014 1,074,302 Costs and Expenses: Salaries, wages and benefits 557,604 59,226 49,233 666,063 Other operating 238,354 16,053 12,347 266,754 Facility rent 32,819 2,064 5,935 40,818 Depreciation and amortization 36,890 443 3,339 40,672 Interest 845 – – 845 Impairment of assets 4,497 – 3,728 8,225 Total costs and expenses 871,009 77,786 74,582 1,023,377 Income (loss) before non-operating income 61,424 19,069 (29,568 ) 50,925 Non-operating income – – 17,774 17,774 Gain on acquisition of equity method investment – – 95,202 95,202 Unrealized losses on marketable equity securities – – (13,863 ) (13,863 ) Income before income taxes $ 61,424 $ 19,069 $ 69,545 $ 150,038 Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods.
Our critical accounting policies that are both important to the portrayal of our financial condition and results and require our most difficult, subjective or complex judgments are as follows: Net Patient Revenues and Accounts Receivable Net patient revenues are derived from services rendered to patients for skilled and intermediate nursing, rehabilitation therapy, assisted living and independent living, home health care services and hospice services.
Our critical accounting policies that are both important to the portrayal of our financial condition and results and require our most difficult, subjective or complex judgments are as follows: Net Patient Revenues and Accounts Receivable Net patient revenues are derived from services rendered to patients for skilled and intermediate nursing, rehabilitation therapy, assisted living and independent living, home health care services, hospice services and behavioral health services.
Guarantees At December 31, 2022, we have no agreements to guarantee the debt obligations of other parties. We have no outstanding letters of credit. We may or may not in the future elect to use financial derivative instruments to hedge interest rate exposure in the future. At December 31, 2022, we did not participate in any such financial instruments.
Guarantees At December 31, 2023, we have no agreements to guarantee the debt obligations of other parties. We have no outstanding letters of credit. We may or may not in the future elect to use financial derivative instruments to hedge interest rate exposure in the future. At December 31, 2023, we did not participate in any such financial instruments.
In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties. We also own the real estate of 13 healthcare properties and lease these properties to third party operators.
In addition, we provide management services, accounting and financial services, and insurance services to third party operators of healthcare properties. We also own the real estate of 10 healthcare properties and lease these properties to third party operators.
Credit losses are recorded as bad debt expense, which is included as a component of other operating expenses in the interim condensed consolidated statements of operations Revenue Recognition – Third Party Payors Medicare and Medicaid program revenues, as well as certain Managed Care program revenues, are subject to audit and retroactive adjustment by government representatives or their agents.
Credit losses are recorded as bad debt expense, which is included as a component of other operating expenses consolidated statements of operations Revenue Recognition – Third Party Payors Medicare and Medicaid program revenues, as well as certain Managed Care program revenues, are subject to audit and retroactive adjustment by government representatives or their agents.
Percentage of Net Operating Revenues Year Ended December 31, 2022 2021 2020 Revenues: Net patient revenues 94.8 % 89.9 % 90.6 % Other revenues 4.2 4.2 4.8 Government stimulus income 1.0 5.9 4.6 Net operating revenues and grant income 100.0 100.0 100.0 Costs and Expenses: Salaries, wages and benefits 63.2 62.0 60.4 Other operating 26.6 24.8 26.8 Facility rent 3.8 3.8 3.9 Depreciation and amortization 3.7 3.8 4.1 Interest 0.1 0.1 0.1 Impairment (recovery) of assets (0.3 ) 0.8 – Total costs and expenses 97.1 95.3 95.3 Income from operations 2.9 4.7 4.7 Non–operating income 1.0 1.7 2.6 Gain on acquisition of equity method investments – 8.8 0.1 Unrealized losses on marketable equity securities (1.4 ) (1.3 ) (2.3 ) Income before income taxes 2.5 13.9 5.1 Income tax provision (0.7 ) (1.0 ) (1.0 ) Net income 1.8 12.9 4.1 Net loss attributable to noncontrolling interest 0.3 0.0 0.0 Net income attributable to common stockholders of NHC 2.1 % 12.9 % 4.1 % 34 Table of Contents The following table sets forth the increase or (decrease) in certain items from the consolidated statements of operations as compared to the prior period (dollars in thousands) .
Percentage of Net Operating Revenues Year Ended December 31, 2023 2022 2021 Revenues: Net patient revenues 95.3 % 94.8 % 89.9 % Other revenues 4.7 4.2 4.2 Government stimulus income – 1.0 5.9 Net operating revenues and grant income 100.0 100.0 100.0 Costs and Expenses: Salaries, wages and benefits 62.4 63.2 62.0 Other operating 25.2 26.6 24.8 Facility rent 3.6 3.8 3.8 Depreciation and amortization 3.7 3.7 3.8 Interest 0.1 0.1 0.1 Impairment (recovery) of assets – (0.3 ) 0.8 Total costs and expenses 95.0 97.1 95.3 Income from operations 5.0 2.9 4.7 Non–operating income 1.5 1.0 1.7 Gain on acquisition of equity method investment – – 8.8 Unrealized gains (losses) on marketable equity securities 1.3 (1.4 ) (1.3 ) Income before income taxes 7.8 2.5 13.9 Income tax provision (2.1 ) (0.7 ) (1.0 ) Net income 5.7 1.8 12.9 Net loss attributable to noncontrolling interest 0.2 0.3 0.0 Net income attributable to common stockholders of NHC 5.9 % 2.1 % 12.9 % 33 Table of Contents The following table sets forth the increase or (decrease) in certain items from the consolidated statements of operations as compared to the prior period (dollars in thousands) .
The Company recorded $11,457,000, $63,360,000 and $47,505,000 of government stimulus income from the Provider Relief Funds for the years ended December 31, 2022, 2021 and 2020, respectively. The grant income was determined on a systemic basis in line with the recognition of specific expenses and lost revenues for which the grants are intended to compensate.
The Company recorded $0, $11,457,000 and $63,360,000 of government stimulus income from the Provider Relief Funds for the years ended December 31, 2023, 2022 and 2021, respectively. The grant income was determined on a systemic basis in line with the recognition of specific expenses and lost revenues for which the grants are intended to compensate.
Specifically, the Company believes the presentation of non-GAAP financial information should exclude the following items: the unrealized gains or losses on our marketable equity securities, operating results for the newly constructed healthcare facilities not at full capacity, any gains on the acquisition of equity method investments, gains on the sale of healthcare facilities, stock-based compensation expense, and impairments or recoveries of long-lived assets and notes receivable.
Specifically, the Company believes the presentation of non-GAAP financial information should exclude the following items: the unrealized gains or losses on our marketable equity securities, operating results for start-up healthcare operations not at full capacity, any gains on the acquisition of equity method investments, gains on the sale of property and equipment, stock-based compensation expense, and impairments or recoveries of long-lived assets and notes receivable.
The operating results for the start-up operations not at full capacity include the following: for the year ended December 31, 2022, included are operations that began from 2020 to 2022, which is two behavioral health hospitals, one hospice agency, and one homecare agency.
The operating results for the start-up operations not at full capacity include the following: for the year ended December 31, 2023, included are operations that began from 2021 to 2023, which is two behavioral health hospitals, two homecare agencies, and two hospice agencies.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2022: NHC Ratings Industry Ratings Total number of skilled nursing facilities, end of period 68 Number of 4 and 5-star rated skilled nursing facilities 42 Percentage of 4 and 5-star rated skilled nursing facilities 62% 37% Average rating for all skilled nursing facilities, end of period 3.8 2.9 30 Table of Contents Development and Growth We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets.
The tables below summarize NHC's overall performance in these Five-Star ratings versus the skilled nursing industry as of December 31, 2023: NHC Ratings Industry Ratings Total number of skilled nursing facilities, end of period 68 Number of 4 and 5-star rated skilled nursing facilities 40 Percentage of 4 and 5-star rated skilled nursing facilities 59% 36% Average rating for all skilled nursing facilities, end of period 3.6 2.9 Development and Growth We are undertaking to expand our post–acute and senior health care operations while protecting our existing operations and markets.
The composite skilled nursing facility per diem increased 2.3% in 2022 compared to 2021. Medicare and managed care per diem rates increased 2.3% and 6.0%, respectively, in 2022 compared to 2021. Medicaid and private pay per diem rates increased 3.0% and 4.7%, respectively, in 2022 compared to 2021.
The composite skilled nursing facility per diem increased 6.7% in 2023 compared to 2022. Medicare and managed care per diem rates increased 3.3% and 5.9%, respectively, in 2023 compared to 2022. Medicaid and private pay per diem rates increased 9.4% and 5.5%, respectively, in 2023 compared to 2022.
Investing Activities Net cash used in investing activities totaled $5,978,000 for the year ended December 31, 2022, as compared to $65,889,000 and $63,878,000 for the years ended December 31, 2021 and 2020, respectively. Cash used for property and equipment additions was $30,200,000, $39,399,000, and $21,873,000 for the years ended December 31, 2022, 2021 and 2020, respectively.
Investing Activities Net cash used in investing activities totaled $17,568,000 for the year ended December 31, 2023, as compared to $5,978,000 and $65,889,000 for the years ended December 31, 2022 and 2021, respectively. Cash used for property and equipment additions was $27,901,000, $30,200,000, and $39,399,000 for the years ended December 31, 2023, 2022 and 2021, respectively.
At December 31, 2022, we operate or manage 68 skilled nursing facilities with 8,726 1icensed beds, 23 assisted living facilities with 1,181 units, five independent living facilities, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies located in 8 states.
At December 31, 2023, we operate or manage 68 skilled nursing facilities with 8,732 1icensed beds, 26 assisted living facilities with 1,501 units, five independent living facilities, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies located in 8 states.
Our ability to obtain long-term debt to meet our long–term contractual obligations and to finance our operating requirements, growth and development plans will depend upon our future performance, which will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for health care, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets.
Our ability to obtain long-term debt to meet our long–term contractual obligations and to finance our operating requirements, growth and development plans will depend upon our future performance, which will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for health care, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets, as well as many unforeseen factors. 38 Table of Contents Contingencies See Note 17 to the consolidated financial statements for additional information on pending litigation and other contingencies.
For the year ended December 31, 2020, included are facilities that began operations from 2018 to 2020, which is one memory care facility. 33 Table of Contents The table below provides reconciliations of GAAP to non-GAAP items ( dollars in thousands, except per share data ): Year Ended December 31, 2022 2021 2020 Net income attributable to National HealthCare Corporation $ 22,445 $ 138,590 $ 41,871 Non-GAAP adjustments: Unrealized losses on marketable equity securities 15,806 13,863 23,966 Gain on sale of real estate/healthcare facilities – – (2,784 ) Gain on acquisition of equity method investment – (95,202 ) (1,707 ) Stock-based compensation expense 2,612 2,620 2,453 Operating results for newly-opened operations not at full capacity 5,416 922 602 Impairment (recovery) of assets (3,728 ) 8,225 – Income tax benefit on non-GAAP adjustments (5,228 ) (6,373 ) (5,858 ) Non-GAAP Net Income $ 37,323 $ 62,645 $ 58,543 GAAP diluted earnings per share $ 1.45 $ 8.99 $ 2.72 Non-GAAP adjustments: Unrealized losses on marketable equity securities 0.76 0.67 1.15 Gain on sale of real estate/healthcare facilities – – (0.13 ) Gain on acquisition of equity method investment – (6.16 ) (0.08 ) Stock-based compensation expense 0.13 0.13 0.12 Operating results for newly-opened operations not at full capacity 0.26 0.04 0.03 Impairment (recovery) of assets (0.18 ) 0.39 – Non-GAAP diluted earnings per share $ 2.42 $ 4.06 $ 3.81 Results of Operations The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2022, 2021 and 2020.
For the year ended December 31, 2021, included are facilities that began operations from 2019 to 2021, which is two behavioral health hospitals and one memory care facility. 32 Table of Contents The table below provides reconciliations of GAAP to non-GAAP items ( dollars in thousands, except per share data ): Year Ended December 31, 2023 2022 2021 Net income attributable to National HealthCare Corporation $ 66,798 $ 22,445 $ 138,590 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (14,944 ) 15,806 13,863 Gain on sale of property and equipment (6,230 ) – – Gain on acquisition of equity method investment – – (95,202 ) Stock-based compensation expense 2,782 2,612 2,620 Operating results for newly-opened operations not at full capacity 2,359 5,416 922 Impairment (recovery) of assets – (3,728 ) 8,225 Income tax expense (benefit) on non-GAAP adjustments 4,169 (5,228 ) (6,373 ) Non-GAAP Net Income $ 54,934 $ 37,323 $ 62,645 GAAP diluted earnings per share $ 4.34 $ 1.45 $ 8.99 Non-GAAP adjustments: Unrealized (gains) losses on marketable equity securities (0.72 ) 0.76 0.67 Gain on sale of property and equipment (0.30 ) – – Gain on acquisition of equity method investment – – (6.16 ) Stock-based compensation expense 0.13 0.13 0.13 Operating results for newly-opened operations not at full capacity 0.10 0.26 0.04 Impairment (recovery) of assets – (0.18 ) 0.39 Non-GAAP diluted earnings per share $ 3.55 $ 2.42 $ 4.06 Results of Operations The following table and discussion set forth items from the consolidated statements of operations as a percentage of net operating revenues and grant income for the years ended December 31, 2023, 2022 and 2021.
Type of Operation Description Size Location Placed in Service Skilled Nursing Acquisition 166 beds Knoxville, TN February 2020 Assisted Living Bed Addition 20 beds Gallatin, TN September 2020 Skilled Nursing Bed Addition 30 beds Kingsport, TN December 2020 Hospice Acquisition 28 agencies Various June 2021 Homecare New Agency 1 agency Anderson, SC January 2022 Hospice New Agency 1 agency Tullahoma, TN March 2022 Behavioral Health Hospital New Facility 64 beds Knoxville, TN April 2022 Behavioral Health Hospital New Facility 16 beds St.
Type of Operation Description Size Location Placed in Service Hospice Acquisition 28 agencies Various June 2021 Homecare New Agency 1 agency Anderson, SC January 2022 Hospice New Agency 1 agency Tullahoma, TN March 2022 Behavioral Health Hospital New Facility 64 beds Knoxville, TN April 2022 Behavioral Health Hospital New Facility 16 beds St.
Income taxes The income tax provision for 2022 is $7,254,000 (an effective income tax rate of 26.6%). 2021 Compared to 2020 Results for the year ended December 31, 2021 compared to 2020 include a 4.5% increase in net operating revenues and grant income and a 231.2% increase in net income attributable to NHC.
Income taxes The income tax provision for 2023 is $23,450,000 (an effective income tax rate of 26.4%). 2022 Compared to 2021 Results for the year ended December 31, 2022 compared to 2021 include a 1.1% increase in net operating revenues and grant income.
Cash provided by operating activities consisted of net income of $19,977,000 and adjustments for non–cash items of $60,697,000. There was cash used for working capital in the amount of $73,697,000 for the year ended December 31, 2022 compared to 40,738,000 in 2021.
Cash provided by operating activities consisted of net income of $65,288,000 and adjustments for non–cash items of $33,625,000. There was cash provided by working capital in the amount of $17,396,000 for the year ended December 31, 2023 compared to cash used for working capital needs in the amount of $73,697,000 in 2022.
The following is a summary of our sources and uses of cash flows (dollars in thousands) : Year Ended One Year Change Year Ended One Year Change 12/31/22 12/31/21 $ % 12/31/21 12/31/20 $ % Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period $ 119,743 $ 158,502 $ (38,759 ) (24.5 ) $ 158,502 $ 61,010 $ 97,492 159.8 Cash provided by operating activities 8,742 62,394 (53,652 ) (86.0 ) 62,394 203,259 (140,865 ) (69.3 ) Cash used in investing activities (5,978 ) (65,889 ) 59,911 90.9 (65,889 ) (63,878 ) (2,011 ) (3.1 ) Cash used in financing activities (47,642 ) (35,264 ) (12,378 ) (35.1 ) (35,264 ) (41,889 ) 6,625 15.8 Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period $ 74,865 $ 119,743 $ (44,878 ) (37.5 ) $ 119,743 $ 158,502 $ (38,759 ) (24.5 ) 38 Table of Contents Operating Activities Net cash provided by operating activities for the year ended December 31, 2022 was $8,742,000 as compared to $62,394,000 and $203,259,000 for the years ended December 31, 2021 and 2020, respectively.
The following is a summary of our sources and uses of cash flows (dollars in thousands) : Year Ended One Year Change Year Ended One Year Change 12/31/23 12/31/22 $ % 12/31/22 12/31/21 $ % Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period $ 74,865 $ 119,743 $ (44,878 ) (37.5 ) $ 119,743 $ 158,502 $ (38,759 ) (24.5 ) Cash provided by operating activities 111,216 8,742 102,474 1,172.2 8,742 62,394 (53,652 ) (86.0 ) Cash used in investing activities (17,568 ) (5,978 ) (11,590 ) (193.9 ) (5,978 ) (65,889 ) 59,911 90.9 Cash used in financing activities (42,545 ) (47,642 ) 5,097 10.7 (47,642 ) (35,264 ) (12,378 ) (35.1 ) Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period $ 125,968 $ 74,865 $ 51,103 68.3 $ 74,865 $ 119,743 $ (44,878 ) (37.5 ) 37 Table of Contents Operating Activities Net cash provided by operating activities for the year ended December 31, 2023 was $111,216,000 as compared to $8,742,000 and $62,394,000 for the years ended December 31, 2022 and 2021, respectively.
For the year ended December 31, 2021, included are facilities that began operations from 2019 to 2021, which is one memory care facility and two behavioral health hospitals.
For the year ended December 31, 2022, included are facilities that began operations from 2020 to 2022, which is two behavioral health hospitals, one hospice agency, and one homecare agency.
In June 2021, the Company acquired the remaining ownership interest in Caris, which resulted in net patient revenues increasing $31,566,000 for the year ended December 31, 2022 compared to the prior year.
Medicaid and private pay per diem rates increased 3.0% and 4.7%, respectively, in 2022 compared to 2021. In June 2021, the Company acquired the remaining ownership interest in Caris, which resulted in net patient revenues increasing $31,566,000 for the year ended December 31, 2022 compared to the prior year.
Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction. Segment Reporting The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services.
Segment Reporting The Company has two reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities, assisted and independent living facilities, and behavioral health hospitals; and (2) homecare and hospice services.
Included in net patient revenues for the year ended December 31, 2022 and 2021, respectively, is $19,442,000 and $20,482,000 of COVID-19 supplemental Medicaid payments that were received to help mitigate the incremental costs in fighting the public health emergency. The overall average census in owned and leased skilled nursing facilities for 2022 was 83.8% compared to 80.6% in 2021.
Included in net patient revenues for the years ended December 31, 2023 and 2022, respectively, is $20,214,000 and $19,442,000 of supplemental Medicaid payments that were received to help mitigate the inflationary labor and medical supplies costs caused by the pandemic. The overall average census in owned and leased skilled nursing facilities for 2023 was 87.9% compared to 83.8% in 2022.
Period to Period Increase (Decrease) 2022 vs. 2021 2021 vs. 2020 Amount Percent Amount Percent Revenues: Net patient revenues $ 63,543 6.6 % $ 33,747 3.6 % Other revenues (204 ) (0.4 ) (3,517 ) (7.2 ) Government stimulus income (51,903 ) (81.9 ) 15,855 33.4 Net operating revenues and grant income 11,436 1.1 46,085 4.5 Costs and Expenses: Salaries, wages and benefits 20,106 3.0 45,071 7.3 Other operating 22,618 8.5 (8,405 ) (3.1 ) Facility rent 159 0.4 324 0.8 Depreciation and amortization (183 ) (0.4 ) (1,346 ) (3.2 ) Interest (282 ) (33.4 ) (554 ) (39.6 ) Impairment (recovery) of assets (11,953 ) (145.3 ) 8,225 100.0 Total costs and expenses 30,465 3.0 43,315 4.4 Income from operations (19,029 ) (37.4 ) 2,770 5.8 Non–operating income (6,633 ) (37.3 ) (8,753 ) (33.0 ) Gain on acquisition of equity method investment (95,202 ) (100.0 ) 93,495 5,477.2 Unrealized losses on marketable equity securities (1,943 ) (14.0 ) 10,103 42.2 Income before income taxes (122,807 ) (81.9 ) 97,615 186.2 Income tax provision 3,697 33.8 (518 ) (5.0 ) Net income (119,110 ) (85.6 ) 97,097 231.2 Net income attributable to noncontrolling interest 2,965 596.6 (378 ) (317.6 ) Net income attributable to common stockholders of NHC $ (116,145 ) (83.8 )% $ 96,719 231.0 % 2022 Compared to 2021 Results for the year ended December 31, 2022 compared to 2021 include a 1.1% increase in net operating revenues and grant income.
Period to Period Increase (Decrease) 2023 vs. 2022 2022 vs. 2021 Amount Percent Amount Percent Revenues: Net patient revenues $ 58,529 5.7 % $ 63,543 6.6 % Other revenues 8,734 19.3 (204 ) (0.4 ) Government stimulus income (11,457 ) (100.0 ) (51,903 ) (81.9 ) Net operating revenues and grant income 55,806 5.1 11,436 1.1 Costs and Expenses: Salaries, wages and benefits 26,175 3.8 20,106 3.0 Other operating (1,189 ) (0.4 ) 22,618 8.5 Facility rent 548 1.3 159 0.4 Depreciation and amortization 1,545 3.8 (183 ) (0.4 ) Interest (239 ) (42.5 ) (282 ) (33.4 ) Impairment (recovery) of assets 3,728 100.0 (11,953 ) (145.3 ) Total costs and expenses 30,568 2.9 30,465 3.0 Income from operations 25,238 79.1 (19,029 ) (37.4 ) Non–operating income 5,519 49.5 (6,633 ) (37.3 ) Gain on acquisition of equity method investment – – (95,202 ) (100.0 ) Unrealized gains (losses) on marketable equity securities 30,750 194.5 (1,943 ) (14.0 ) Income before income taxes 61,507 225.9 (122,807 ) (81.9 ) Income tax provision (16,196 ) (223.3 ) 3,697 33.8 Net income 45,311 226.8 (119,110 ) (85.6 ) Net (income) loss attributable to noncontrolling interest (958 ) (38.8 ) 2,965 596.6 Net income attributable to common stockholders of NHC $ 44,353 197.6 % $ (116,145 ) (83.8 )% 2023 Compared to 2022 Results for the year ended December 31, 2023 compared to 2022 include a 5.1% increase in net operating revenues and grant income.
Net operating revenues and grant income Net patient revenues totaled $1,029,085,000, an increase of $63,543,000, or 6.6%, compared to the prior year.
Net operating revenues and grant income Net patient revenues totaled $1,087,614,000 an increase of $58,529,000, or 5.7%, compared to the prior year.
We received cash distributions from our unconsolidated investments of $439,000 during the year ended December 31, 2022, compared to $6,314,000 in the prior year. Included in the adjustments for non-cash items are depreciation expense, equity in earnings of unconsolidated investments, unrealized losses on our marketable equity securities, recovery of assets, deferred taxes, and stock compensation.
Included in the adjustments for non-cash items are depreciation expense, equity in earnings of unconsolidated investments, unrealized losses on our marketable equity securities, recovery of assets, deferred taxes, and stock compensation.
The new laws impacted healthcare providers in a variety of ways, but the largest legislation from a monetary relief perspective is the CARES Act. Through the CARES Act, as well as the PPPCHE, the federal government allocated $178 billion to the Public Health and Social Services Emergency Fund, which is referred to as the Provider Relief Fund.
Through the CARES Act, as well as the PPPCHE, the federal government allocated $178 billion to the Public Health and Social Services Emergency Fund, which is referred to as the Provider Relief Fund.
As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents.
We have set aside restricted cash and restricted marketable securities to fund our professional liability and workers’ compensation reserves. As to exposure for professional liability claims, we have developed performance measures to bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls.
Liquidity, Capital Resources and Financial Condition Sources and Uses of Funds Our primary sources of cash include revenues from the operations of our healthcare operations, management and accounting services, rental income, and investment income.
Income taxes The income tax provision for 2022 is $7,254,000 (an effective income tax rate of 26.6%). 36 Table of Contents Liquidity, Capital Resources and Financial Condition Sources and Uses of Funds Our primary sources of cash include revenues from the operations of our healthcare operations, management and accounting services, rental income, and investment income.
Proceeds from the sale of marketable securities, net of purchases, resulted in cash proceeds of $16,168,000 in 2022. In 2021, we had purchases of marketable securities, net of sales, that resulted in a net use of cash of $6,267,000. The Company collected notes receivable of $3,879,000 and $8,840,000 for the years ended December 31, 2022 and 2021, respectively.
Proceeds from the sale of marketable securities, net of purchases, resulted in cash proceeds of $17,895,000 and $16,168,000 in 2023 and 2022, respectively. For the year ended December 31, 2022, the Company collected notes receivable of $3,879,000 and received proceeds from the sale of property and equipment of $4,175,000.
The Company’s assessment of whether the terms and conditions for amounts received have been met for income recognition and the Company’s related income calculation considered all frequently asked questions and other interpretive guidance issued to date by HHS. 29 Table of Contents Additionally, as part of the CARES Act, the legislation included an expansion of the Medicare Accelerated and Advance Payment Program.
The Company’s assessment of whether the terms and conditions for amounts received have been met for income recognition and the Company’s related income calculation considered all frequently asked questions and other interpretive guidance issued to date by HHS. 29 Table of Contents Executive Summary Earnings To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues.
Executive Summary Earnings To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues. Inflationary increases in our costs may cause net earnings from patient services to decline. Occupancy A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities.
During certain inflationary times, our net patient revenues and government reimbursement may not keep pace with inflationary increases in our expenses, which may cause net earnings to decline. Occupancy A primary area of management focus continues to be the rates of occupancy within our skilled nursing facilities.
Proceeds from the issuance of common stock totaled $2,114,000, $3,441,000, and $1,756,000 for 2022, 2021 and 2020, respectively. We repurchased common shares outstanding in the amount of $9,903,000, $836,000, and $53,000 for the years ended December 31, 2022, 2021, and 2020, respectively.
We repurchased common shares outstanding in the amount of $2,482,000, $9,903,000, and $836,000 for the years ended December 31, 2023, 2022, and 2021, respectively. Short – term liquidity We expect to meet our short–term liquidity requirements primarily from our cash flows from operating activities.
Included in net patient revenues for the year end December 31, 2021 and 2020, respectively, is $20,482,000 and $26,179,000 of COVID-19 supplemental Medicaid payments that were received to help mitigate the incremental costs in fighting the public health emergency. The overall average census in owned and leased skilled nursing facilities for 2021 was 80.6% compared to 83.6% in 2020.
Net operating revenues and grant income Net patient revenues totaled $1,029,085,000, an increase of $63,543,000, or 6.6%, compared to the prior year. Included in net patient revenues for the year ended December 31, 2022 and 2021, respectively, is $19,442,000 and $20,482,000 of supplemental Medicaid payments that were received to help mitigate the incremental costs in fighting the pandemic.
In addition to cash flows from operations, our current cash on hand of $58,667,000 and unrestricted marketable securities of $123,922,000 are expected to be adequate to meet our contractual obligations, operating liquidity, and our growth and development plans in the next twelve months.
In addition to cash flows from operations, we have current cash on hand of $107,076,000 and unrestricted marketable equity and debt securities of $116,544,000. We also have unencumbered real estate, as well the borrowing capacity on our $50 million credit facility, that can be used to meet our contractual obligations and growth and development plans in the next twelve months.
For the years ended December 31, 2021 and 2020, respectively, we recorded $63,360,000 and $47,505,000 in government stimulus income related to funds received from the Provider Relief Fund.
For the years ended December 31, 2023 and 2022, respectively, we recorded $0 and $11,457,000 in government stimulus income related to funds received from the CARES Act Provider Relief Fund. Total costs and expenses Total costs and expenses for 2023 increased $30,568,000, or 2.9%, to $1,084,410,000 from $1,053,842,000 in 2022.
Principal payments made under finance lease obligations was $4,695,000, $4,423,000, and $4,166,000 for the years ended December 31, 2022, 2021, and 2020, respectively. Dividends paid to common stockholders was $34,604,000, $32,030,000, and $31,921,000 for the years ended December 31, 2022, 2021 and 2020, respectively.
Financing Activities Net cash used in financing activities totaled $42,545,000, $47,642,000, and $35,264,000 for the years ended December 31, 2023, 2022, and 2021, respectively. Principal payments made under finance lease obligations was $4,985,000, $4,695,000, and $4,423,000 for the years ended December 31, 2023, 2022, and 2021, respectively.
Long – term liquidity We expect to meet our long–term liquidity requirements primarily from our cash flows from operating activities, our current cash on hand of $58,667,000, and unrestricted marketable securities of $123,922,000. We also have substantial value in our unencumbered real estate assets which could potentially be used as collateral in future borrowing opportunities.
Long – term liquidity We expect to meet our long–term liquidity requirements primarily from our cash flows from operating activities, our current cash on hand of $107,076,000, our unrestricted marketable equity and debt securities of $116,544,000, and our borrowing capacity on the $50 million credit facility.
Medicare and managed care per diem rates increased 2.0% and 1.3%, respectively, in 2021 compared to 2020. Medicaid and private pay per diem rates increased 2.2% and 2.4%, respectively, in 2021 compared to 2020.
The overall average census in owned and leased skilled nursing facilities for 2022 was 83.8% compared to 80.6% in 2021. The composite skilled nursing facility per diem increased 2.3% in 2022 compared to 2021. Medicare and managed care per diem rates increased 2.3% and 6.0%, respectively, in 2022 compared to 2021.
Our Caris acquisition increased other operating expenses $8,368,000 for the year ended December 31, 2021 compared to 2020. 37 Table of Contents Facility rent expense decreased $324,000, or 0.8%, to $40,818,000. Depreciation and amortization decreased 3.2% to $40,672,000. Interest expense decreased $554,000 to $845,000 in 2021 from $1,399,000 in 2020. At December 31, 2021, we have no outstanding long-term debt.
We continue to face inflationary pressures in certain categories within other operating expenses as well, such as food/dietary supplies and drugs/pharmaceutical supplies. Facility rent expense increased $548,000, or 1.3%, to $41,525,000. Depreciation and amortization increased 3.8% to $42,034,000. Interest expense decreased $239,000 to $324,000 in 2023 from $563,000 in 2022. At December 31, 2023, we have no outstanding long-term debt.
For the year ended December 31, 2021, GAAP net income attributable to NHC was $138,590,000 compared to net income of $41,871,000 for the same period in 2020. The large increase in our reported GAAP 2021 net income compared to 2020 is primarily due to the $95.2 million gain recorded from the acquisition of Caris, a hospice provider.
For the year ended December 31, 2023, GAAP net income attributable to NHC was $66,798,000 compared to net income of $22,445,000 for the same period in 2022.
Excluding the gain on the Caris acquisition, as well as the unrealized losses in our marketable equity securities portfolio and the other non-GAAP adjustments, non-GAAP net income for the year ended December 31, 2021 was $62,645,000 compared to $58,543,000 for the year ended December 31, 2020. 36 Table of Contents Net operating revenues and grant income Net patient revenues totaled $965,542,000, an increase of $33,747,000, or 3.6%, compared to the prior year.
Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income was $54,934,000 for the year ended December 31, 2023 compared to $37,323,000 for the same period a year ago.
In November 2020, the Company sold a skilled nursing facility located in Town & Country, Missouri. For the year ended December 31, 2021, the sale of this facility decreased net patient revenue by $7,323,000 compared to 2020. Other revenues in 2021 were $45,400,000, a decrease of $3,517,000, or 7.2%, as further detailed in Note 4 of the consolidated financial statements.
In September 2022, the Company transferred the operations of seven skilled nursing facilities located in Massachusetts and New Hampshire, which resulted in net patient revenues decreasing $48,820,000 for the year ended December 31, 2023 compared to the same period last year. 34 Table of Contents Other revenues in 2023 were $53,930,000, an increase of $8,734,000, or 19.3%, as further detailed in Note 4 to our consolidated financial statements.
For the year ended December 31, 2021, our agency nurse staffing expenses were $36,391,000 compared to $11,686,000 for the 2020 year. Other operating expenses decreased $8,405,000, or 3.1%, to $266,754,000 for 2021 compared to $275,159,000 in 2020. These costs were 24.8% and 26.8% of net operating revenues and grant income for 2021 and 2020, respectively.
Other operating expenses decreased $1,189,000, or 0.4%, to $288,183,000 for the year ended December 31, 2023 compared to $289,372,000 for the prior year. Other operating expenses as a percentage of net operating revenues and grant income was 25.2% and 26.7% for the years ended December 31, 2023 and 2022, respectively.
Louis, MO June 2022 Accrued Risk Reserves Our accrued professional liability and workers’ compensation reserves totaled $102,469,000 and $98,048,000 at December 31, 2022 and 2021, respectively, and are a primary area of management focus. We have set aside restricted cash and restricted marketable securities to fund our professional liability and workers’ compensation reserves.
Louis, MO June 2022 Hospice New Agency 1 agency Cedar Bluff, VA March 2023 Skilled Nursing Acquisition 66 beds Nashville, TN May 2023 Homecare New Agency 1 agency Tallahassee, FL May 2023 Assisted Living Facility New Operations 135 units Vero Beach, FL July 2023 Assisted Living Facility New Operations 95 units Merritt Island, FL July 2023 Assisted Living Facility New Operations 100 units Stuart, FL July 2023 Accrued Risk Reserves Our accrued professional liability and workers’ compensation reserves totaled $103,259,000 and $102,469,000 at December 31, 2023 and 2022, respectively, and are a primary area of management focus.